ClinicalTrials.Veeva

Menu

Canadian Cohort of Convective Thermal Therapy Using Rezūm System in Benign Prostatic Hyperplasia (BPH).

C

Can-Am HIFU

Status

Enrolling

Conditions

Urologic Diseases

Treatments

Procedure: Rezum

Study type

Observational

Funder types

Other

Identifiers

NCT05201131
Rezum in BPH CAN

Details and patient eligibility

About

To document the clinical outcome of Rezūm therapy for BPH patient in Canadian cohort.

Enrollment

50 estimated patients

Sex

Male

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Male subjects of ≥ 18 years of age.
  • Primary diagnosis of Benign Prostate Hypertrophy (BPH).
  • Candidate for Rezūm therapy as per clinical decision of Investigator.
  • Willing and able to accurately complete the required questionnaires.
  • Willing and able to provide signed and dated informed consent

Exclusion criteria

  • Characteristics indicating a poor compliance with study protocol requirements.
  • Disease or other health condition that is not suitable for this study.
  • Unable or unwilling to provide signed informed consent.

Trial design

50 participants in 1 patient group

Rezum procedure
Treatment:
Procedure: Rezum

Trial contacts and locations

1

Loading...

Central trial contact

Iris Chan; Dean Elterman

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems